Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1974 1
1975 1
1976 2
1977 2
1978 2
1979 2
1980 1
1981 4
1982 1
1983 5
1984 6
1985 3
1986 4
1987 10
1988 6
1989 3
1990 6
1991 6
1992 12
1993 15
1994 20
1995 18
1996 15
1997 18
1998 13
1999 31
2000 20
2001 30
2002 21
2003 27
2004 23
2005 19
2006 23
2007 30
2008 32
2009 29
2010 34
2011 34
2012 36
2013 37
2014 19
2015 27
2016 18
2017 14
2018 12
2019 12
2020 12
2021 8
2022 17
2023 21
2024 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

723 results

Results by year

Filters applied: . Clear all
Page 1
AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
Matsuoka K, Watanabe M, Ohmori T, Nakajima K, Ishida T, Ishiguro Y, Kanke K, Kobayashi K, Hirai F, Watanabe K, Mizusawa H, Kishida S, Miura Y, Ohta A, Kajioka T, Hibi T; AJM300 Study Group. Matsuoka K, et al. Among authors: mizusawa h. Lancet Gastroenterol Hepatol. 2022 Jul;7(7):648-657. doi: 10.1016/S2468-1253(22)00022-X. Epub 2022 Mar 30. Lancet Gastroenterol Hepatol. 2022. PMID: 35366419 Clinical Trial.
Prion diseases, always a threat?
Saitoh Y, Mizusawa H. Saitoh Y, et al. Among authors: mizusawa h. J Neurol Sci. 2024 Aug 15;463:123119. doi: 10.1016/j.jns.2024.123119. Epub 2024 Jul 1. J Neurol Sci. 2024. PMID: 39029285 Review.
Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxia: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Zesiewicz TA, Wilmot G, Kuo SH, Perlman S, Greenstein PE, Ying SH, Ashizawa T, Subramony SH, Schmahmann JD, Figueroa KP, Mizusawa H, Schöls L, Shaw JD, Dubinsky RM, Armstrong MJ, Gronseth GS, Sullivan KL. Zesiewicz TA, et al. Among authors: mizusawa h. Neurology. 2018 Mar 6;90(10):464-471. doi: 10.1212/WNL.0000000000005055. Epub 2018 Feb 9. Neurology. 2018. PMID: 29440566 Free PMC article.
Iatrogenic Creutzfeldt-Jakob disease.
Kobayashi A, Kitamoto T, Mizusawa H. Kobayashi A, et al. Among authors: mizusawa h. Handb Clin Neurol. 2018;153:207-218. doi: 10.1016/B978-0-444-63945-5.00012-X. Handb Clin Neurol. 2018. PMID: 29887137
Metronidazole-induced encephalopathy.
Higashi M, Irioka T, Matsumoto T, Mizusawa H. Higashi M, et al. Among authors: mizusawa h. Intern Med. 2013;52(7):843-4. doi: 10.2169/internalmedicine.52.9496. Epub 2013 Apr 1. Intern Med. 2013. PMID: 23545693 Free article. No abstract available.
FUS regulates RAN translation through modulating the G-quadruplex structure of GGGGCC repeat RNA in C9orf72-linked ALS/FTD.
Fujino Y, Ueyama M, Ishiguro T, Ozawa D, Ito H, Sugiki T, Murata A, Ishiguro A, Gendron T, Mori K, Tokuda E, Taminato T, Konno T, Koyama A, Kawabe Y, Takeuchi T, Furukawa Y, Fujiwara T, Ikeda M, Mizuno T, Mochizuki H, Mizusawa H, Wada K, Ishikawa K, Onodera O, Nakatani K, Petrucelli L, Taguchi H, Nagai Y. Fujino Y, et al. Among authors: mizusawa h. Elife. 2023 Jul 18;12:RP84338. doi: 10.7554/eLife.84338. Elife. 2023. PMID: 37461319 Free PMC article.
[Corticobasal degeneration].
Mizusawa H. Mizusawa H. Rinsho Shinkeigaku. 1997 Dec;37(12):1131-3. Rinsho Shinkeigaku. 1997. PMID: 9577668 Japanese.
Consensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias.
Mitoma H, Adhikari K, Aeschlimann D, Chattopadhyay P, Hadjivassiliou M, Hampe CS, Honnorat J, Joubert B, Kakei S, Lee J, Manto M, Matsunaga A, Mizusawa H, Nanri K, Shanmugarajah P, Yoneda M, Yuki N. Mitoma H, et al. Among authors: mizusawa h. Cerebellum. 2016 Apr;15(2):213-32. doi: 10.1007/s12311-015-0664-x. Cerebellum. 2016. PMID: 25823827 Free PMC article. Review.
[Recommendations (Proposal) for promoting research for overcoming neurological diseases 2020].
Mochizuki H, Aoki M, Ikenaka K, Inoue H, Iwatsubo T, Ugawa Y, Okazawa H, Ono K, Onodera O, Kitagawa K, Saito Y, Shimohata T, Takahashi R, Toda T, Nakahara J, Matsumoto R, Mizusawa H, Mitsui J, Murayama S, Katsuno M; Future Vision Committee of Japanese Society of Neurology; Aoki Y, Ishiura H, Izumi Y, Koike H, Shimada H, Takahashi Y, Tokuda T, Nakajima H, Hatano T, Misawa S, Watanabe H. Mochizuki H, et al. Among authors: mizusawa h. Rinsho Shinkeigaku. 2022 Jun 24;62(6):443-457. doi: 10.5692/clinicalneurol.cn-001696. Epub 2022 May 28. Rinsho Shinkeigaku. 2022. PMID: 35644580 Japanese.
High-dose ubiquinol supplementation in multiple-system atrophy: a multicentre, randomised, double-blinded, placebo-controlled phase 2 trial.
Mitsui J, Matsukawa T, Uemura Y, Kawahara T, Chikada A, Porto KJL, Naruse H, Tanaka M, Ishiura H, Toda T, Kuzuyama H, Hirano M, Wada I, Ga T, Moritoyo T, Takahashi Y, Mizusawa H, Ishikawa K, Yokota T, Kuwabara S, Sawamoto N, Takahashi R, Abe K, Ishihara T, Onodera O, Matsuse D, Yamasaki R, Kira JI, Katsuno M, Hanajima R, Ogata K, Takashima H, Matsushima M, Yabe I, Sasaki H, Tsuji S. Mitsui J, et al. Among authors: mizusawa h. EClinicalMedicine. 2023 Apr 14;59:101920. doi: 10.1016/j.eclinm.2023.101920. eCollection 2023 May. EClinicalMedicine. 2023. PMID: 37256098 Free PMC article.
723 results